San Antonio — Rapamycin Holdings, a life sciences business working to commercialize a new formulation of an immunosuppressant as a prostate ...
News
- Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO
- Rapamycin Holdings, Inc. Rebrands to Emtora Biosciences as New Leadership Focuses Company ...
SAN ANTONIO--(BUSINESS WIRE)--Feb 26, 2019--Rapamycin Holdings, ... The rebrand to Emtora Biosciences enables a dynamic and meaningful ...
- Eni (E) Initiates Construction of 31MW Photovoltaic Plant
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They're also finding ...
- Another San Antonio biotech changing its name and CEO
San Antonio-based Rapamycin Holdings Inc. has changed its top executive, as well as its name. Carole Spangler Vaughn has been named CEO of ...
- Texas Makes Move to Lure Companies to the State to Enhance Its Biotech Industry
That life sciences center in San Antonio isn't the only recruitment being undertaken in Texas. Robert Allen, president and chief executive officer of the ...